A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma
Clinical trial NCT01390948 · COMPLETED
Trial details
- NCT number
- NCT01390948
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-18
- Primary completion
- 2016-02-05
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.